Clinical Trials

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT05343936 2026-03-18

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Active not recruiting

490 enrolled

Prostatic Neoplasms

NCT04344899 2026-03-11

PORTS

Completed

74 enrolled

Pelvic Neoplasms

NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Not yet recruiting

85 enrolled

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT05812807 2026-03-04

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

1,295 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT05976763 2026-03-04

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

421 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT04425421 2026-03-02

GFALMB2019

1,000 enrolled

Lymphoid

Burkitt Lymphoma

NCT04425434 2026-03-02

GFARB12019

3,000 enrolled

Other solid neoplasm

Retinoblastoma

NCT05840484 2026-02-19

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

100 enrolled

Phase 4 Not yet recruiting

Prostatic Neoplasms

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

25 enrolled

Endometrial Neoplasms

NCT07405476 2026-02-12

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

38 enrolled

LymphoidOther hematologic neoplasm

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03516617 2026-02-09

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2 Recruiting

120 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Phase EARLY_PHASE1 Active not recruiting

34 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06733350 2026-02-09

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Suspended

600 enrolled

Prostatic Neoplasms

NCT05810467 2026-02-04

AS

200 enrolled

Prostatic Neoplasms

NCT07370675 2026-01-27

Active Surveillance for Bethesda IV Thyroid Nodules

165 enrolled

Phase 2/3 Active not recruiting

Thyroid Neoplasms, Thyroid Nodule

NCT05710406 2026-01-26

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

1 enrolled

Phase EARLY_PHASE1 Recruiting

Colonic Neoplasms

NCT07025226 2026-01-26

Senolytics

10 enrolled

CNS

Glioma

NCT02914873 2026-01-20

PCASTT

Phase NA Active not recruiting

2,008 enrolled

Phase NA Active not recruiting

Prostatic Neoplasms

NCT06411938 2026-01-16

Merck-3

2,300 enrolled

Uterine Cervical Neoplasms

NCT06745024 2026-01-15

Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial

Phase NA Not yet recruiting

280 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07240220 2026-01-15

Merck-4

2,500 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

163 enrolled

CNS

Meningioma

NCT06378866 2025-12-26

DIVINE

Phase 2 Recruiting

532 enrolled

Prostatic Neoplasms

NCT03803553 2025-12-23

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

400 enrolled

Colonic Neoplasms

NCT07270861 2025-12-08

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

3,000 enrolled

Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT07262138 2025-12-03

ACTIVE

50 enrolled

LymphoidOther hematologic neoplasm

Breast Neoplasms

NCT06792994 2025-12-02

CLL2000

Not yet recruiting

2,000 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03594630 2025-11-06

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

Phase EARLY_PHASE1 Recruiting

120 enrolled

Phase 2 Active not recruiting

Rectal Neoplasms

NCT04519879 2025-10-29

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

133 enrolled

Prostatic Neoplasms

NCT02882282 2025-10-23

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase 2 Completed

15 enrolled 8 charts

Mouth Neoplasms

NCT06200103 2025-09-11

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Phase 2 Recruiting

236 enrolled

Prostatic Neoplasms

NCT02609685 2025-09-09

PMCAS

216 enrolled

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms

NCT03911128 2025-09-02

A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

LymphoidOther hematologic neoplasm

500 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

688 enrolled

Urinary Bladder Neoplasms

NCT07023432 2025-06-17

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

78 enrolled

Carcinoma, Renal Cell

NCT05375617 2025-05-31

EPICkids

CNSLymphoidOther hematologic neoplasm

1,400 enrolled

Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06998342 2025-05-31

MOHSAHRTSS

24 enrolled

Head and Neck Neoplasms

NCT06861894 2025-05-15

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

164 enrolled

Esophageal Squamous Cell Carcinoma

NCT06974370 2025-05-15

ACTION-Brain

45 enrolled

CNS

Brain Neoplasms

NCT00949819 2025-05-13

ASCaP

462 enrolled

Phase 2/3 Active not recruiting

Prostatic Neoplasms

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

635 enrolled 9 charts

Colonic Neoplasms

NCT04625023 2025-05-01

METAMECH

1,500 enrolled

Breast Neoplasms

NCT05873608 2025-04-10

Communication Issues in Patient and Provider Discussions of Immunotherapy

125 enrolled

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06539468 2025-04-02

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients